Want to join the conversation?
$MJN said that its strategy to drive growth of higher value product and product forms is working. This helps offset the impact of increased investments above the net sales line. The company's Fuel for Growth cost reduction initiative drove significant reduction in SG&A. Overall, these costs were down 9% from constant dollars in 2Q16 vs. 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?